ELAN(Elanco Animal Health Incorporated) · 财务报表

ELAN(Elanco Animal Health Incorporated) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$4.76B$4.41B$4.42B$4.44B$4.71B
毛利润$2.63B$2.50B$2.49B$2.44B$2.59B
营业利润—————
净利润−$483.00M−$78.00M−$1.23B$338.00M−$232.00M
经营现金流$483.00M$452.00M$271.00M$541.00M$560.00M
自由现金流$324.00M$281.00M$131.00M$394.00M$284.00M
摊薄每股收益$-0.99$-0.16$-2.50$0.68$-0.47

Elanco Animal Health Incorporated ELAN